Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Twist Bioscience Corporat...

    NASDAQ: TWST · Real-Time Price · USD
    35.01
    1.49 (4.45%)
    At close: Jun 16, 2025, 3:59 PM
    35.00
    -0.04%
    Pre-market: Jun 17, 2025, 08:07 AM EDT

    Twist Bioscience Statistics

    Share Statistics

    Twist Bioscience has 59.92M shares outstanding. The number of shares has increased by 2.45% in one year.

    Shares Outstanding

    n/a
    		 59.92M

    Shares Change (YoY)

    n/a
    		 2.45%

    Shares Change (QoQ)

    n/a
    		 0.5%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 56.69M

    Failed to Deliver (FTD) Shares

    n/a
    		 601

    FTD / Avg. Volume

    n/a
    		 0.05%

    Short Selling Information

    The latest short interest is 10.68M, so 17.83% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 10.68M

    Short % of Shares Out

    n/a
    		 17.83%

    Short % of Float

    n/a
    		 20.14%

    Short Ratio (days to cover)

    n/a
    		 9.38

    Valuation Ratios

    The PE ratio is -12.56 and the forward PE ratio is -24.67. Twist Bioscience's PEG ratio is 0.

    PE Ratio

    n/a
    		 -12.56

    Forward PE

    n/a
    		 -24.67

    PS Ratio

    n/a
    		 8.38

    Forward PS

    n/a
    		 2.9

    PB Ratio

    n/a
    		 5.55

    P/FCF Ratio

    n/a
    		 -37.89

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Twist Bioscience.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.88, with a Debt / Equity ratio of 0.18.

    Current Ratio

    n/a
    		 4.88

    Quick Ratio

    n/a
    		 4.54

    Debt / Equity

    n/a
    		 0.18

    Debt / EBITDA

    n/a
    		 -0.48

    Debt / FCF

    n/a
    		 -1.23

    Interest Coverage

    n/a
    		 -7614.86

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $339,083.42

    Profits Per Employee

    n/a
    		 $-226,138.68

    Employee Count

    n/a
    		 923

    Asset Turnover

    n/a
    		 0.51

    Inventory Turnover

    n/a
    		 7.46

    Taxes

    Income Tax

    n/a
    		 560K

    Effective Tax Rate

    n/a
    		 -0.27%

    Stock Price Statistics

    The stock price has increased by -28.55% in the last 52 weeks. The beta is 2.37, so Twist Bioscience's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.37

    52-Week Price Change

    n/a
    		 -28.55%

    50-Day Moving Average

    n/a
    		 34.1

    200-Day Moving Average

    n/a
    		 42.15

    Relative Strength Index (RSI)

    n/a
    		 58.9

    Average Volume (20 Days)

    n/a
    		 1,210,253

    Income Statement

    In the last 12 months, Twist Bioscience had revenue of 312.97M and earned -208.73M in profits. Earnings per share was -3.6.

    Revenue

    n/a
    		 312.97M

    Gross Profit

    n/a
    		 133.35M

    Operating Income

    n/a
    		 -220.83M

    Net Income

    n/a
    		 -208.73M

    EBITDA

    n/a
    		 -176.71M

    EBIT

    n/a
    		 -208.14M

    Earnings Per Share (EPS)

    n/a
    		 -3.6
    Full Income Statement

    Balance Sheet

    The company has 226.32M in cash and 85.03M in debt, giving a net cash position of 141.29M.

    Cash & Cash Equivalents

    n/a
    		 226.32M

    Total Debt

    n/a
    		 85.03M

    Net Cash

    n/a
    		 141.29M

    Retained Earnings

    n/a
    		 -1.24B

    Total Assets

    n/a
    		 595.62M

    Working Capital

    n/a
    		 263.47M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -64.09M and capital expenditures -5.08M, giving a free cash flow of -69.17M.

    Operating Cash Flow

    n/a
    		 -64.09M

    Capital Expenditures

    n/a
    		 -5.08M

    Free Cash Flow

    n/a
    		 -69.17M

    FCF Per Share

    n/a
    		 -1.19
    Full Cash Flow Statement

    Margins

    Gross margin is 42.61%, with operating and profit margins of -70.56% and -66.69%.

    Gross Margin

    n/a
    		 42.61%

    Operating Margin

    n/a
    		 -70.56%

    Pretax Margin

    n/a
    		 -66.51%

    Profit Margin

    n/a
    		 -66.69%

    EBITDA Margin

    n/a
    		 -56.46%

    EBIT Margin

    n/a
    		 -70.56%

    FCF Margin

    n/a
    		 -22.1%

    Dividends & Yields

    TWST does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TWST is $50, which is 42.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $50

    Price Target Difference

    n/a
    		 42.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 6.73

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist